Literature DB >> 26975496

Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach.

Yuji Seo1, Keisuke Tamari1, Yasuo Yoshioka1, Fumiaki Isohashi1, Osamu Suzuki1, Kazuhiko Hayashi1, Yutaka Takahashi1, SungJae Baek1, Keisuke Otani1, Kazuhiko Ogawa1.   

Abstract

OBJECTIVE: It is unclear whether radiosensitization is beneficial when radiotherapy is administered at a high dose per fraction. The aim of this study was to assess the impact of radiation dose on the effectiveness of a broad range of radiosensitizers.
METHODS: We analyzed 653 pairs of clonogenic survival curves in 285 published articles, in which modifications of radiosensitivity were studied using the colony-forming assay. The modifications of radiosensitivity were arbitrarily classified into 20 classes. The survival curves were fitted to two biomathematical models: the linear-quadratic model and the repair-misrepair (RMR) model.
RESULTS: We found that radiosensitization was predominantly characterized by an increase of the α value (α-sensitization) without an increase of the β value (β-sensitization). A subset analysis revealed that all 20 classes showed significant α-sensitization. In contrast, only oxygen/hypoxic sensitizers (oxygen) and poly(adenosine diphosphate-ribose) polymerase inhibition (PARPi) exhibited β-sensitization. An analysis using the RMR model revealed two major sources of radiosensitization: an increased residual DNA lesion through repair inhibition and a shift from linear repairs to quadratic misrepairs, leading to enhanced lethal chromosomal aberrations.
CONCLUSION: Oxygen and PARPi were found to show β-sensitization, which was favourable for eliciting a comparable degree of sensitization in the higher dose range. Reduced fidelity of the repair was suggested to be a possible mechanism of β-sensitization. Further study targeting β-sensitization is needed to develop a novel combined modality therapy with high-dose-per-fraction radiotherapy. ADVANCES IN KNOWLEDGE: Radiosensitization can be classified into two groups, α- and β-sensitizations. These two phenomena may stem from distinct underlying mechanisms.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26975496      PMCID: PMC5258145          DOI: 10.1259/bjr.20150724

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  32 in total

1.  Requirement for repair of DNA double-strand breaks by homologous recombination in split-dose recovery.

Authors:  H Utsumi; M M Elkind
Journal:  Radiat Res       Date:  2001-05       Impact factor: 2.841

Review 2.  Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity.

Authors:  Chao Liu; Qun Lin; Zhong Yun
Journal:  Radiat Res       Date:  2015-05-04       Impact factor: 2.841

3.  Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice.

Authors:  Kiyoko Kato; Kazuhiro Nakajima; Ayako Ui; Yuri Muto-Terao; Hideaki Ogiwara; Shinichiro Nakada
Journal:  Mol Cell       Date:  2014-02-20       Impact factor: 17.970

4.  The repair-misrepair model in radiobiology: comparison to other models.

Authors:  C A Tobias
Journal:  Radiat Res Suppl       Date:  1985

5.  Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.

Authors:  J Martin Brown; Maximilian Diehn; Billy W Loo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-01       Impact factor: 7.038

6.  Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. II. Radiosensitization of human colon cancer cells by bromodeoxyuridine.

Authors:  E M Miller; J F Fowler; T J Kinsella
Journal:  Radiat Res       Date:  1992-07       Impact factor: 2.841

7.  Stereotactic body radiotherapy for central lung tumors.

Authors:  Bryan P Rowe; Daniel J Boffa; Lynn D Wilson; Anthony W Kim; Frank C Detterbeck; Roy H Decker
Journal:  J Thorac Oncol       Date:  2012-09       Impact factor: 15.609

8.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Authors:  Niklas Schultz; Elena Lopez; Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

9.  Homologous recombination mediates cellular resistance and fraction size sensitivity to radiation therapy.

Authors:  Navita Somaiah; John Yarnold; Anne Lagerqvist; Kai Rothkamm; Thomas Helleday
Journal:  Radiother Oncol       Date:  2013-06-05       Impact factor: 6.280

10.  PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.

Authors:  Minli Wang; Weizhong Wu; Wenqi Wu; Bustanur Rosidi; Lihua Zhang; Huichen Wang; George Iliakis
Journal:  Nucleic Acids Res       Date:  2006-11-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.